
Cigna (CI) Stock Forecast & Price Target
Cigna (CI) Analyst Ratings
Bulls say
Cigna Group is a leading provider of pharmacy benefit management and health insurance services with a positive outlook due to strong performance in its PBM and specialty pharmacy services, strategic partnerships with top insurers and employers, and a focus on expanding its Evernorth capabilities. The company's decision to exit the individual ACA exchange business and its commitment to diversity in leadership are also positive factors. However, risks include potential economic impact from this exit, a strategic review of its prior authorization unit, and declines in PBM earnings and scripts.
Bears say
Cigna Group is facing multiple risks, such as high healthcare costs and margin erosion in its PBMs, slow biosimilar adoption, and potential client losses. Despite being undervalued and having a strong diversified business, its potential challenges may hinder its growth. The company's response to the COVID-19 pandemic and initiatives to support customers and communities may help mitigate some risks, but overall its outlook is negative due to potential headwinds in the healthcare industry and risks to its key drivers of growth.
This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.
Cigna (CI) Analyst Forecast & Price Prediction
Start investing in Cigna (CI)
Order type
Buy in
Order amount
Est. shares
0 shares